He said the Swiss government would not agree to a full waiver of the rights but it was willing to continue discussions.
Parmelin was speaking on the sidelines of a meeting of the World Trade Organization (WTO)External link in the Swiss city of Geneva on Wednesday as the conference was extended by one day to reach a consensus on changes to global trade rules.
“It’s not part of Switzerland’s policy to leave a discussion,” Parmelin was quoted as saying by the Keystone-SDA news agency.
He added that it was in nobody’s interest to block negotiations and some of the 164 WTO member states were holding their cards close to their chests.
Nevertheless, Parmelin said a deal was still possible, but he dismissed a proposal by non-governmental organisations for a temporary waiver of IP rights.
Any departure from basic principles in the IP rights was inacceptable for Switzerland’s pharmaceutical industry, he explained.
India, South Africa and other developing countries have sought exceptions for vaccines, treatments and diagnostics for more than a year, but they came up against opposition from Switzerland and Britain. Both countries have major pharmaceutical producers.
The WTO ministerial meeting, originally due to end on Wednesday, is the first major conference in four years.
More
More
Will WTO break deadlock in next major meeting?
This content was published on
The 12th Ministerial Conference of the World Trade Organization (WTO), postponed twice due to Covid, will finally take place from Sunday in Geneva.
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
This content was published on
Three independent UN experts call on Switzerland and other countries to redouble efforts a year after a ECHR ruling in favour of Climate Elders.
“No US tariff negotiations”: Swiss economics minister
This content was published on
Switzerland has yet to enter formal tariff negotiations with the United States despite making contact with the administration.
Soaring cocoa prices hit Swiss chocolate maker Barry Callebaut
This content was published on
Swiss chocolate maker Barry Callebaut suffered from soaring cocoa prices in the first half of the 2024-2025 financial year.
Switzerland faces income losses from US tariffs, says ETH Zurich
This content was published on
Compared to Germany and France, Switzerland would face “significantly higher losses,” says ETH Zurich’s Centre for Economic Research (KOF).
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.